Conversely, inhibiting PTEN/p53-deficient PCa-cell-derived lactate efflux using the PI3K inhibitor copanlisib reduces histone acylation and promotes TAM activation/phagocytosis. The gene discussed is TP53; the disease is posterior cortical atrophy.